Temporal variations in the pharmacokinetics of isoniazid and N-acetylisoniazid in rats. 1989

P M Belanger, and M Lalande, and F M Dore, and G Labrecque
Ecole de pharmacie, Faculté de médecine, Université Laval.

The temporal variation in the pharmacokinetics of a single dose administration of isoniazid (INH) and its major metabolite, N-acetylisoniazid (AINH), was investigated at 0900 and 2100 in rats synchronized to a 12-hr light-dark cycle. INH and AINH were administered by the intraarterial and ip routes at a dose of 20 mg/kg, in order to determine the hepatic extraction ratio of both compounds. The mean AUC values of INH obtained after the intraarterial and ip injections of the drug were 42.6 and 8.4 micrograms.hr/ml at 0900 and 30.7 and 12.8 micrograms.hr/ml at 2100, respectively. Consequently, there were temporal variations (mean values at 0900 and 2100) in the clearance (491.6 and 665.3 ml/hr/kg), bioavailability (0.20 and 0.42), hepatic extraction ratio of INH (0.80 and 0.58), and apparent hepatic blood flow (9.7 and 18.6 ml/min). Also, the AUC of AINH was higher at 2100 when INH was injected intraarterially. Likewise, AINH had a lower t 1/2 and AUC values and a higher clearance at 2100, but the hepatic extraction ratio of AINH was 0.26 at 2100 compared with the value of 0.07 at 0900. No diurnal variations were present in the apparent volume of distribution of INH and AINH. In vitro experiments showed that the mean activity of the hepatic N-acetyltransferase was 135.3 nmol/mg at 2100, compared with 59.0 nmol/mg at 0900.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D001783 Blood Flow Velocity A value equal to the total volume flow divided by the cross-sectional area of the vascular bed. Blood Flow Velocities,Flow Velocities, Blood,Flow Velocity, Blood,Velocities, Blood Flow,Velocity, Blood Flow
D000123 Acetyltransferases Enzymes catalyzing the transfer of an acetyl group, usually from acetyl coenzyme A, to another compound. EC 2.3.1. Acetyltransferase
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

P M Belanger, and M Lalande, and F M Dore, and G Labrecque
January 2022, Frontiers in pharmacology,
P M Belanger, and M Lalande, and F M Dore, and G Labrecque
January 1988, Therapeutic drug monitoring,
P M Belanger, and M Lalande, and F M Dore, and G Labrecque
April 1983, Zhonghua jie he he hu xi xi ji bing za zhi = Chinese journal of tuberculosis and respiratory diseases,
P M Belanger, and M Lalande, and F M Dore, and G Labrecque
September 1976, Research communications in chemical pathology and pharmacology,
P M Belanger, and M Lalande, and F M Dore, and G Labrecque
January 2011, Drug metabolism and drug interactions,
P M Belanger, and M Lalande, and F M Dore, and G Labrecque
May 1988, British journal of clinical pharmacology,
P M Belanger, and M Lalande, and F M Dore, and G Labrecque
January 2023, Journal of pharmacy & bioallied sciences,
P M Belanger, and M Lalande, and F M Dore, and G Labrecque
May 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
P M Belanger, and M Lalande, and F M Dore, and G Labrecque
July 1985, International journal of clinical pharmacology, therapy, and toxicology,
P M Belanger, and M Lalande, and F M Dore, and G Labrecque
March 1967, Tubercle,
Copied contents to your clipboard!